Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Novimmune S.A.
DescriptionHuman mAb against interferon (IFN) gamma
Molecular Target Interferon (IFN) gamma
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase II
Standard Indication Hematology (unspecified)
Indication DetailsTreat primary hemophagocytic lymphohistiocytosis (HLH)
Regulatory Designation EU - Orphan Drug (Treat primary hemophagocytic lymphohistiocytosis (HLH))

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today